Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Tenax Therapeutics, Inc.
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Tenax Therapeutics, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Tenax Therapeutics, Inc. since 2005.
The reporting company's ticker symbol is TENX. The reporting company's CIK number is 34956.
The total value of stock buying since 2005 is $68,920.
The total value of stock sales since 2005 is $5,050.
The total value of stock option exercises since 2005 is $0.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2017-12-18||Blanck Ronald R||Buy||12,950||.46||5,892|
|2017-11-14||Blanck Ronald R||Sale||12,950||.39||5,050|
|2016-11-23||Proehl Gerald T (Director)||Buy||14,449||1.76||25,430|
|2016-11-22||Proehl Gerald T (Director)||Buy||15,433||1.59||24,538|
|2015-11-19||Blanck Ronald R (Director)||Buy||1,900||3.20||6,080|
|2015-01-20||Blanck Ronald R (Director)||Buy||2,000||3.49||6,980|
Insider trading activities including stock purchases, stock sales, and option exercises of TENX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Tenax Therapeutics, Inc. (symbol TENX, CIK number 34956) see the Securities and Exchange Commission (SEC) website.